Red Rock Pharmacy (Utah): 503A Compounding Pharmacy Public Record

Red Rock Pharmacy is a compounding pharmacy in Springville, Utah. Some telehealth programs use compounding pharmacies like this one to prepare compounded GLP-1 medications. This page lists what public records and the pharmacy’s own website showed on October 17, 2026, with the source for each fact, so you can check the record yourself.

At a glance

Who they are

The legal name in federal records is CD Pharmacy, LLC, doing business as Red Rock Pharmacy. On its website the pharmacy calls itself Red Rock Compounding Pharmacy, and the site’s copyright line reads Red Rock Home Pharmacy.

The pharmacy says it began as a long-term care pharmacy in Salt Lake City and has compounded since 2017, with a focus that includes hormone replacement, peptide therapies, and work with telemedicine programs. It says it serves patients in 49 states. Its contact page lists two compounding locations:

• Springville, Utah (863 W 450 S, Ste 101; NPI 1548795461), which the pharmacy says serves all states except California, Nevada, and Arkansas
• St. George, Utah (1240 East 100 South, Suite 220; NPI 1134653579), which the pharmacy says serves California and Nevada

A related long-term care pharmacy business operates under the Red Rock Pharmacy name at redrockrx.com. This profile covers the compounding pharmacy.

What a compounding pharmacy does

A compounding pharmacy prepares a medication for an individual patient rather than dispensing a mass-manufactured product. For an injectable like a compounded GLP-1, that means preparing the medication under sterile conditions to a specific prescription.

Because each preparation is made by the pharmacy that fills it, the pharmacy’s own practices and inspection record matter. That is why public records such as licenses, FDA inspection findings, and warning letters are worth checking for any pharmacy a program uses.

Public record as of October 17, 2026

The July 2026 FDA inspection

FDA inspected the Springville facility from July 21 to July 31, 2026, and issued a Form FDA 483 on July 31, 2026. A Form 483 lists observations made by the FDA investigator. The form itself states that the observations “do not represent a final Agency determination” of compliance.

The form lists ten observations:

• Observation 1: the firm released drug product whose strength, purity, or quality differed from what it was represented to possess. The form describes a suspected glass particle found in one vial of a liraglutide injection lot, solution from that lot filled as a new lot with a beyond-use date 24 days past the original, inadequate stability data for the original lot’s roughly 90-day beyond-use date, no confirmation of the particle’s identity or source, and units dispensed from the new lot.
• Observations 2 to 7 and 9: media fills and smoke studies that did not simulate routine production, sterile items exposed to air below ISO 5 quality, and aseptic technique and glove-sanitizing practices observed while staff filled compounded semaglutide and tirzepatide-methylcobalamin injection lots.
• Observation 8: a pressure gauge used in post-use filter-integrity testing for sterile lots had not been calibrated in about three years of use.
• Observation 10: cleaning and decontamination after producing hazardous-drug capsules.

FDA’s page did not list a warning letter or close-out letter for this inspection when checked on October 17, 2026. Read the full document on FDA’s site, linked in the sources below.

What the pharmacy says about itself

These are the pharmacy’s own statements, not findings by Transformation Health or a regulator. The pharmacy says it is a 503A compounding pharmacy that follows USP chapters 795, 797, and 800 (non-sterile compounding, sterile compounding, and hazardous drug handling). It says it uses ingredients from FDA-registered suppliers. It also says it sends compounded medications for third-party laboratory testing, and that each batch “may be tested” for potency, sterility, endotoxin, and stability depending on the formulation. Its website shows a LegitScript seal image; Transformation Health could not confirm LegitScript status on October 17, 2026, because the LegitScript lookup requires an interactive check. You can run that check yourself.

How to verify Red Rock Pharmacy yourself

Every record above is public. To check the current record:

1. State license: search the Utah Division of Professional Licensing (DOPL) license lookup for “CD Pharmacy” or the license numbers above, and check the board of pharmacy in your own state, since a pharmacy that ships to you may need a license there.
2. FDA record: open FDA’s “Compounding: Inspections, Recalls, and other Actions” page and find “CD Pharmacy LLC” for the Form 483 and any later letters. Search the FDA warning letter database for the pharmacy’s names.
3. NPI: look up the NPI numbers above in the NPPES NPI Registry.
4. LegitScript: enter the pharmacy’s website in LegitScript’s certification lookup.
5. Your medication: if a program sends your prescription to this pharmacy, ask for the certificate of analysis for your lot.

The full checklist is in How to Vet a Compounding Pharmacy, and a longer guide is in How to Choose a Safe Compounding Pharmacy.

If a program uses Red Rock Pharmacy

At most telehealth programs, you do not choose the pharmacy; the program sends the prescription to a pharmacy it works with. Before your first order, ask the program which pharmacy will prepare your medication and which location will fill it. If it is Red Rock Pharmacy, you can ask the program and the pharmacy how the observations in the July 2026 Form 483 were addressed, and ask the pharmacy for the certificate of analysis for your lot. The pharmacy’s name should also appear on your medication label. A licensed provider decides whether a prescription is appropriate.

The bottom line

Red Rock Pharmacy (CD Pharmacy, LLC) is a 503A compounding pharmacy in Springville, Utah, with a second location in St. George. As of October 17, 2026, FDA’s public record shows a Form 483 with ten observations issued on July 31, 2026, and no warning letter. The pharmacy lists licenses in 49 states and the District of Columbia. Records change, so check the sources before you rely on any of this.

What to read next

For the other pharmacy profiles and safety guides, see Compounding Pharmacy Profiles and Safety Guides. To understand what a licensed pharmacy does that an unregulated seller does not, read The Grey Market: Why Overseas GLP-1s and Peptides Are a Gamble.

Sources

All sources checked October 17, 2026.

• FDA. Compounding: Inspections, Recalls, and other Actions (entry: CD Pharmacy LLC, dba Red Rock Pharmacy, Springville, UT). Content current as of 10/05/2026.
• FDA. Form FDA 483, CD Pharmacy, LLC dba Red Rock Pharmacy, issued 07/31/2026 (PDF).
• FDA. Warning Letters database.
• FDA. Registered Outsourcing Facilities. Updated as of 09/30/2026.
• CMS. NPPES NPI Registry, NPIs 1548795461 and 1134653579.
• Red Rock Pharmacy. Licenses, Quality, About Us, and Contact pages.
• Utah Division of Professional Licensing. License lookup.
• LegitScript. Certification lookup.